| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Androgen | 43 | 2026 | 419 | 6.540 |
Why?
|
| Prostatic Neoplasms | 45 | 2022 | 1419 | 4.970 |
Why?
|
| Receptors, Progesterone | 63 | 2015 | 680 | 4.400 |
Why?
|
| Calcitriol | 19 | 2011 | 62 | 2.780 |
Why?
|
| Receptors, Calcitriol | 15 | 2017 | 59 | 2.320 |
Why?
|
| Gene Expression Regulation, Neoplastic | 20 | 2026 | 2013 | 2.290 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 6 | 2026 | 100 | 1.560 |
Why?
|
| Receptors, Steroid | 10 | 2013 | 172 | 1.560 |
Why?
|
| Androgens | 13 | 2022 | 272 | 1.460 |
Why?
|
| Vitamin D | 9 | 2017 | 194 | 1.450 |
Why?
|
| Alternative Splicing | 6 | 2026 | 313 | 1.340 |
Why?
|
| Cyclin-Dependent Kinase 2 | 8 | 2015 | 53 | 1.280 |
Why?
|
| Cell Line, Tumor | 29 | 2026 | 3708 | 1.210 |
Why?
|
| Transcription, Genetic | 34 | 2018 | 1398 | 1.170 |
Why?
|
| Phosphorylation | 47 | 2014 | 1572 | 1.070 |
Why?
|
| Signal Transduction | 35 | 2018 | 4693 | 1.010 |
Why?
|
| Cell Proliferation | 17 | 2017 | 2483 | 0.970 |
Why?
|
| Transcriptional Activation | 14 | 2012 | 417 | 0.950 |
Why?
|
| G1 Phase | 4 | 2011 | 65 | 0.940 |
Why?
|
| Tumor Cells, Cultured | 30 | 2015 | 989 | 0.920 |
Why?
|
| Serine Endopeptidases | 2 | 2017 | 199 | 0.890 |
Why?
|
| Serine | 12 | 2014 | 163 | 0.870 |
Why?
|
| Androgen Antagonists | 10 | 2022 | 114 | 0.850 |
Why?
|
| Transcription Factors | 17 | 2009 | 2442 | 0.720 |
Why?
|
| Nuclear Receptor Coactivator 1 | 10 | 2011 | 162 | 0.720 |
Why?
|
| Transcriptional Regulator ERG | 3 | 2017 | 39 | 0.720 |
Why?
|
| Cyclin-Dependent Kinases | 5 | 2007 | 83 | 0.690 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2013 | 88 | 0.690 |
Why?
|
| RNA Splicing | 2 | 2021 | 236 | 0.640 |
Why?
|
| HeLa Cells | 19 | 2015 | 694 | 0.600 |
Why?
|
| Neoplasms, Hormone-Dependent | 4 | 2006 | 92 | 0.590 |
Why?
|
| Animals | 88 | 2018 | 34460 | 0.580 |
Why?
|
| Apoptosis | 13 | 2015 | 1860 | 0.580 |
Why?
|
| Neoplasm Proteins | 3 | 2021 | 677 | 0.570 |
Why?
|
| Hormones | 3 | 2015 | 165 | 0.550 |
Why?
|
| Histone Acetyltransferases | 9 | 2009 | 224 | 0.550 |
Why?
|
| Humans | 116 | 2026 | 131967 | 0.540 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2015 | 825 | 0.540 |
Why?
|
| CDC2-CDC28 Kinases | 3 | 2005 | 20 | 0.530 |
Why?
|
| Cell Nucleus | 11 | 2007 | 567 | 0.520 |
Why?
|
| Male | 59 | 2026 | 65357 | 0.520 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2013 | 106 | 0.520 |
Why?
|
| Progesterone | 18 | 2005 | 446 | 0.510 |
Why?
|
| Calcium Channel Agonists | 3 | 2005 | 11 | 0.510 |
Why?
|
| Nuclear Receptor Coactivator 2 | 3 | 2008 | 150 | 0.500 |
Why?
|
| Nuclear Receptor Coactivators | 2 | 2014 | 60 | 0.480 |
Why?
|
| COS Cells | 15 | 2018 | 249 | 0.480 |
Why?
|
| HSP90 Heat-Shock Proteins | 2 | 2013 | 39 | 0.480 |
Why?
|
| Trans-Activators | 4 | 2014 | 692 | 0.470 |
Why?
|
| Transfection | 21 | 2011 | 960 | 0.470 |
Why?
|
| Cell Division | 8 | 2005 | 731 | 0.460 |
Why?
|
| Tretinoin | 6 | 2005 | 97 | 0.460 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 2 | 2014 | 44 | 0.460 |
Why?
|
| Chickens | 28 | 2000 | 286 | 0.440 |
Why?
|
| Cyclin A2 | 1 | 2014 | 4 | 0.440 |
Why?
|
| DNA-Binding Proteins | 16 | 2006 | 1964 | 0.430 |
Why?
|
| Metabolomics | 2 | 2015 | 493 | 0.430 |
Why?
|
| Steroid Hydroxylases | 1 | 2014 | 19 | 0.430 |
Why?
|
| Nitriles | 10 | 2017 | 165 | 0.420 |
Why?
|
| Cell Cycle | 7 | 2012 | 598 | 0.420 |
Why?
|
| Gene Fusion | 1 | 2014 | 60 | 0.420 |
Why?
|
| Medical Oncology | 1 | 2015 | 238 | 0.390 |
Why?
|
| Models, Biological | 5 | 2017 | 1396 | 0.390 |
Why?
|
| Endocrinology | 1 | 2015 | 128 | 0.380 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2013 | 72 | 0.380 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2015 | 1236 | 0.380 |
Why?
|
| Genes, myc | 2 | 2011 | 95 | 0.370 |
Why?
|
| Blotting, Western | 11 | 2015 | 1018 | 0.370 |
Why?
|
| Periodicals as Topic | 1 | 2015 | 181 | 0.370 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 9 | 2000 | 20 | 0.370 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 611 | 0.370 |
Why?
|
| DNA-Activated Protein Kinase | 3 | 2026 | 28 | 0.370 |
Why?
|
| Protein Isoforms | 4 | 2026 | 421 | 0.360 |
Why?
|
| Oviducts | 16 | 1992 | 100 | 0.360 |
Why?
|
| Receptors, Retinoic Acid | 5 | 2006 | 76 | 0.350 |
Why?
|
| Mifepristone | 9 | 2015 | 89 | 0.350 |
Why?
|
| CDC2 Protein Kinase | 1 | 2011 | 36 | 0.340 |
Why?
|
| RNA, Messenger | 8 | 2015 | 2573 | 0.340 |
Why?
|
| Binding Sites | 11 | 2012 | 1204 | 0.330 |
Why?
|
| Retinoblastoma Protein | 1 | 2011 | 78 | 0.330 |
Why?
|
| Peptide Fragments | 6 | 2012 | 782 | 0.320 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 388 | 0.320 |
Why?
|
| Steroids | 5 | 2005 | 172 | 0.320 |
Why?
|
| Cell Line | 18 | 2018 | 2607 | 0.320 |
Why?
|
| Prostate | 7 | 2018 | 415 | 0.320 |
Why?
|
| Antineoplastic Agents | 5 | 2018 | 1812 | 0.310 |
Why?
|
| Nuclear Proteins | 9 | 2007 | 1228 | 0.300 |
Why?
|
| Cyclins | 2 | 2007 | 94 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-akt | 6 | 2018 | 482 | 0.290 |
Why?
|
| Molecular Sequence Data | 26 | 2003 | 3616 | 0.290 |
Why?
|
| DNA | 15 | 2007 | 1440 | 0.280 |
Why?
|
| Carcinoma | 1 | 2011 | 283 | 0.280 |
Why?
|
| Parathyroid Hormone-Related Protein | 4 | 2009 | 10 | 0.280 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 5 | 2009 | 173 | 0.270 |
Why?
|
| Breast Neoplasms | 10 | 2014 | 2653 | 0.270 |
Why?
|
| Phosphotransferases | 2 | 2007 | 33 | 0.270 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2010 | 246 | 0.270 |
Why?
|
| Gene Expression | 7 | 2016 | 1503 | 0.260 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2007 | 329 | 0.260 |
Why?
|
| Amino Acid Sequence | 19 | 2002 | 2566 | 0.260 |
Why?
|
| Promoter Regions, Genetic | 15 | 2008 | 1219 | 0.260 |
Why?
|
| Genes, Reporter | 8 | 2005 | 350 | 0.260 |
Why?
|
| Anilides | 5 | 2016 | 53 | 0.260 |
Why?
|
| Down-Regulation | 7 | 2011 | 659 | 0.260 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2005 | 76 | 0.250 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2007 | 88 | 0.250 |
Why?
|
| Real-Time Polymerase Chain Reaction | 4 | 2015 | 533 | 0.250 |
Why?
|
| Mice | 22 | 2018 | 18504 | 0.250 |
Why?
|
| Mutation | 11 | 2011 | 6200 | 0.250 |
Why?
|
| Ligands | 11 | 2006 | 486 | 0.240 |
Why?
|
| Cyclin A | 2 | 2009 | 17 | 0.240 |
Why?
|
| Vitamin D3 24-Hydroxylase | 2 | 2017 | 11 | 0.240 |
Why?
|
| Phosphoprotein Phosphatases | 3 | 2005 | 112 | 0.230 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 2005 | 11 | 0.230 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2005 | 43 | 0.230 |
Why?
|
| Metribolone | 4 | 2006 | 28 | 0.230 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2005 | 738 | 0.220 |
Why?
|
| Gene Expression Profiling | 3 | 2022 | 1841 | 0.220 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2018 | 99 | 0.220 |
Why?
|
| Hindlimb Suspension | 1 | 2004 | 14 | 0.220 |
Why?
|
| Tosyl Compounds | 5 | 2016 | 24 | 0.220 |
Why?
|
| Gene Expression Regulation | 12 | 2011 | 2357 | 0.220 |
Why?
|
| Structure-Activity Relationship | 6 | 2013 | 579 | 0.210 |
Why?
|
| Bone Resorption | 1 | 2004 | 50 | 0.210 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2014 | 233 | 0.210 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2011 | 1281 | 0.210 |
Why?
|
| Glucuronosyltransferase | 2 | 2022 | 64 | 0.210 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 664 | 0.200 |
Why?
|
| Heat-Shock Proteins | 6 | 2002 | 178 | 0.200 |
Why?
|
| Vitamin D Deficiency | 1 | 2004 | 85 | 0.200 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2003 | 18 | 0.200 |
Why?
|
| Receptors, Glucocorticoid | 6 | 2009 | 105 | 0.190 |
Why?
|
| Gravitation | 1 | 2002 | 11 | 0.190 |
Why?
|
| Repressor Proteins | 4 | 2009 | 781 | 0.190 |
Why?
|
| Plasmids | 11 | 2005 | 455 | 0.190 |
Why?
|
| Purines | 3 | 2015 | 115 | 0.190 |
Why?
|
| Androgen Receptor Antagonists | 3 | 2012 | 41 | 0.190 |
Why?
|
| Protein Conformation | 8 | 2002 | 812 | 0.180 |
Why?
|
| Promegestone | 8 | 2015 | 21 | 0.180 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 3 | 2016 | 51 | 0.180 |
Why?
|
| Butadienes | 3 | 2013 | 22 | 0.180 |
Why?
|
| Protein Kinases | 3 | 1992 | 322 | 0.170 |
Why?
|
| Recombinant Proteins | 13 | 2015 | 1319 | 0.170 |
Why?
|
| Protein Binding | 12 | 2007 | 1712 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 462 | 0.170 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 9 | 1997 | 260 | 0.170 |
Why?
|
| HEK293 Cells | 2 | 2021 | 811 | 0.170 |
Why?
|
| Up-Regulation | 5 | 2014 | 832 | 0.170 |
Why?
|
| Chromatin | 3 | 2022 | 495 | 0.170 |
Why?
|
| Mutant Proteins | 1 | 2021 | 113 | 0.170 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 4 | 2003 | 159 | 0.170 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 6 | 2005 | 60 | 0.160 |
Why?
|
| Enzyme Inhibitors | 4 | 2005 | 566 | 0.160 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2017 | 1000 | 0.160 |
Why?
|
| Neoplasms | 1 | 2015 | 2965 | 0.160 |
Why?
|
| Retinoid X Receptors | 4 | 2005 | 24 | 0.160 |
Why?
|
| Mutagenesis, Site-Directed | 6 | 2005 | 300 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 4 | 2012 | 723 | 0.160 |
Why?
|
| Cells, Cultured | 6 | 2010 | 2963 | 0.150 |
Why?
|
| Orchiectomy | 2 | 2013 | 52 | 0.150 |
Why?
|
| HSP40 Heat-Shock Proteins | 2 | 2018 | 22 | 0.150 |
Why?
|
| Base Sequence | 14 | 2008 | 2783 | 0.150 |
Why?
|
| Receptors, Estrogen | 4 | 2009 | 731 | 0.150 |
Why?
|
| Integrin alpha6beta4 | 2 | 2009 | 2 | 0.140 |
Why?
|
| Hormone Antagonists | 3 | 2009 | 45 | 0.140 |
Why?
|
| Protein Stability | 2 | 2009 | 166 | 0.140 |
Why?
|
| Phosphopeptides | 6 | 2000 | 25 | 0.140 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2018 | 72 | 0.140 |
Why?
|
| Ethers, Cyclic | 3 | 1994 | 13 | 0.140 |
Why?
|
| Phenylthiohydantoin | 1 | 2017 | 14 | 0.140 |
Why?
|
| Lipid Metabolism | 1 | 2021 | 372 | 0.140 |
Why?
|
| Oncogene Protein p55(v-myc) | 1 | 2017 | 4 | 0.130 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 1610 | 0.130 |
Why?
|
| Dihydrotestosterone | 3 | 2003 | 72 | 0.130 |
Why?
|
| Immunoenzyme Techniques | 2 | 2015 | 237 | 0.130 |
Why?
|
| Menstrual Cycle | 1 | 1997 | 35 | 0.130 |
Why?
|
| Diet | 1 | 2004 | 1118 | 0.130 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 173 | 0.130 |
Why?
|
| Nutritional Status | 1 | 1999 | 300 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2010 | 1626 | 0.130 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 1996 | 45 | 0.130 |
Why?
|
| Heterografts | 1 | 2017 | 195 | 0.130 |
Why?
|
| Hexosamines | 2 | 2016 | 18 | 0.120 |
Why?
|
| Tumor Burden | 1 | 2017 | 239 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2013 | 620 | 0.120 |
Why?
|
| Acetylation | 2 | 2008 | 181 | 0.120 |
Why?
|
| Benzoquinones | 2 | 2013 | 19 | 0.120 |
Why?
|
| Lactams, Macrocyclic | 2 | 2013 | 33 | 0.120 |
Why?
|
| Drug Interactions | 2 | 2007 | 241 | 0.120 |
Why?
|
| Female | 31 | 2015 | 71316 | 0.120 |
Why?
|
| Journal Impact Factor | 1 | 2015 | 25 | 0.120 |
Why?
|
| Triazoles | 2 | 2014 | 144 | 0.110 |
Why?
|
| Adenoviridae | 2 | 2001 | 586 | 0.110 |
Why?
|
| Gene Transfer Techniques | 1 | 1997 | 343 | 0.110 |
Why?
|
| Mice, Nude | 5 | 2018 | 714 | 0.110 |
Why?
|
| Gonanes | 4 | 2015 | 13 | 0.110 |
Why?
|
| GATA2 Transcription Factor | 1 | 2014 | 46 | 0.110 |
Why?
|
| Histones | 3 | 2008 | 537 | 0.110 |
Why?
|
| Castration | 1 | 2014 | 31 | 0.110 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2015 | 193 | 0.110 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2014 | 30 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 5 | 2000 | 1012 | 0.110 |
Why?
|
| Aromatase Inhibitors | 1 | 2014 | 78 | 0.100 |
Why?
|
| Hydroxamic Acids | 2 | 2005 | 59 | 0.100 |
Why?
|
| Cell Movement | 2 | 2015 | 886 | 0.100 |
Why?
|
| Peptides | 5 | 2000 | 834 | 0.100 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2014 | 274 | 0.100 |
Why?
|
| Substrate Specificity | 3 | 2009 | 287 | 0.100 |
Why?
|
| Uterus | 1 | 1997 | 546 | 0.100 |
Why?
|
| Cell Growth Processes | 3 | 2011 | 62 | 0.100 |
Why?
|
| Transcriptome | 2 | 2017 | 1141 | 0.100 |
Why?
|
| Cytoplasm | 3 | 2005 | 254 | 0.100 |
Why?
|
| Genetic Vectors | 4 | 2005 | 907 | 0.100 |
Why?
|
| Kinetics | 10 | 2000 | 1105 | 0.090 |
Why?
|
| Estrogen Receptor alpha | 2 | 2014 | 433 | 0.090 |
Why?
|
| Employee Performance Appraisal | 1 | 2012 | 12 | 0.090 |
Why?
|
| Peer Review | 1 | 2012 | 36 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2016 | 345 | 0.090 |
Why?
|
| Rats | 8 | 2009 | 3462 | 0.090 |
Why?
|
| Tamoxifen | 2 | 2014 | 350 | 0.090 |
Why?
|
| Prostate-Specific Antigen | 1 | 2012 | 236 | 0.090 |
Why?
|
| Alanine | 3 | 2003 | 163 | 0.090 |
Why?
|
| Awards and Prizes | 1 | 2012 | 63 | 0.090 |
Why?
|
| Ki-67 Antigen | 2 | 2003 | 106 | 0.090 |
Why?
|
| Schools, Medical | 1 | 2012 | 115 | 0.090 |
Why?
|
| Genes, bcl-2 | 1 | 2011 | 10 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2010 | 955 | 0.090 |
Why?
|
| E2F Transcription Factors | 1 | 2011 | 27 | 0.090 |
Why?
|
| Phosphoserine | 3 | 2006 | 38 | 0.080 |
Why?
|
| Drug Synergism | 3 | 2003 | 239 | 0.080 |
Why?
|
| Teaching | 1 | 2012 | 196 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2009 | 195 | 0.080 |
Why?
|
| Peptide Mapping | 6 | 2000 | 40 | 0.080 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 4684 | 0.080 |
Why?
|
| Cell Cycle Proteins | 2 | 2012 | 705 | 0.080 |
Why?
|
| Oncogene Fusion | 1 | 2010 | 26 | 0.080 |
Why?
|
| Cyclic AMP | 3 | 2003 | 230 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2011 | 202 | 0.080 |
Why?
|
| Thymidine | 2 | 2006 | 52 | 0.080 |
Why?
|
| Trypsin | 5 | 1997 | 83 | 0.080 |
Why?
|
| Cell Count | 1 | 2010 | 217 | 0.080 |
Why?
|
| Antibodies | 3 | 2004 | 358 | 0.080 |
Why?
|
| Cyproterone Acetate | 1 | 2009 | 11 | 0.080 |
Why?
|
| Vitamins | 1 | 2010 | 115 | 0.080 |
Why?
|
| Mice, Knockout | 2 | 2018 | 3864 | 0.070 |
Why?
|
| Faculty, Medical | 1 | 2012 | 271 | 0.070 |
Why?
|
| Saccharomyces cerevisiae | 4 | 1993 | 405 | 0.070 |
Why?
|
| Introns | 2 | 2006 | 288 | 0.070 |
Why?
|
| Threonine | 3 | 2003 | 62 | 0.070 |
Why?
|
| RNA, Untranslated | 1 | 2009 | 106 | 0.070 |
Why?
|
| RNA, Neoplasm | 1 | 2008 | 127 | 0.070 |
Why?
|
| 3T3 Cells | 2 | 2005 | 121 | 0.070 |
Why?
|
| Wnt Proteins | 1 | 2009 | 201 | 0.070 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 3 | 2003 | 32 | 0.070 |
Why?
|
| Mammary Tumor Virus, Mouse | 3 | 2005 | 99 | 0.070 |
Why?
|
| Feedback | 2 | 2007 | 149 | 0.070 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2009 | 257 | 0.070 |
Why?
|
| Carrier Proteins | 5 | 2004 | 1025 | 0.070 |
Why?
|
| Point Mutation | 3 | 2003 | 339 | 0.070 |
Why?
|
| Cytosol | 5 | 1996 | 140 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2007 | 1146 | 0.060 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2006 | 17 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 305 | 0.060 |
Why?
|
| RNA, Long Noncoding | 1 | 2009 | 231 | 0.060 |
Why?
|
| Molecular Weight | 8 | 1992 | 297 | 0.060 |
Why?
|
| Mass Spectrometry | 2 | 2013 | 363 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2005 | 244 | 0.060 |
Why?
|
| Vitamin D Response Element | 1 | 2005 | 1 | 0.060 |
Why?
|
| Calcium | 2 | 2001 | 1043 | 0.060 |
Why?
|
| Acid Phosphatase | 1 | 2005 | 13 | 0.060 |
Why?
|
| cdc25 Phosphatases | 1 | 2005 | 18 | 0.060 |
Why?
|
| Phosphotyrosine | 1 | 2005 | 30 | 0.060 |
Why?
|
| Protein Phosphatase 2C | 1 | 2005 | 61 | 0.060 |
Why?
|
| Drug Stability | 2 | 2002 | 58 | 0.060 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 125 | 0.060 |
Why?
|
| Genes, p53 | 1 | 2005 | 213 | 0.060 |
Why?
|
| Acetyltransferases | 1 | 2005 | 73 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 61 | 0.060 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2005 | 73 | 0.060 |
Why?
|
| Disease Progression | 2 | 2016 | 2226 | 0.060 |
Why?
|
| Oligopeptides | 1 | 2005 | 123 | 0.060 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 85 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2007 | 372 | 0.050 |
Why?
|
| Imidazoles | 2 | 2005 | 222 | 0.050 |
Why?
|
| Blood Proteins | 1 | 2005 | 140 | 0.050 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 191 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2009 | 452 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2004 | 236 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2012 | 772 | 0.050 |
Why?
|
| Progestins | 2 | 1996 | 42 | 0.050 |
Why?
|
| Alkaline Phosphatase | 1 | 2004 | 95 | 0.050 |
Why?
|
| Calcium, Dietary | 1 | 2004 | 37 | 0.050 |
Why?
|
| Models, Genetic | 2 | 2005 | 752 | 0.050 |
Why?
|
| Lysine | 1 | 2005 | 175 | 0.050 |
Why?
|
| Pyridines | 1 | 2005 | 260 | 0.050 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 145 | 0.050 |
Why?
|
| Protein Kinase C | 3 | 2018 | 114 | 0.050 |
Why?
|
| Exons | 1 | 2006 | 769 | 0.050 |
Why?
|
| Estrogens | 4 | 1997 | 436 | 0.050 |
Why?
|
| Growth Substances | 1 | 2004 | 102 | 0.050 |
Why?
|
| Microscopy | 1 | 2004 | 122 | 0.050 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2004 | 105 | 0.050 |
Why?
|
| DAX-1 Orphan Nuclear Receptor | 1 | 2003 | 7 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 3 | 1999 | 358 | 0.050 |
Why?
|
| Spodoptera | 2 | 2000 | 28 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2003 | 23 | 0.050 |
Why?
|
| Receptors, Interferon | 1 | 2003 | 20 | 0.050 |
Why?
|
| Testosterone Congeners | 1 | 2003 | 15 | 0.050 |
Why?
|
| Serum Response Factor | 1 | 2003 | 31 | 0.050 |
Why?
|
| Osteoblasts | 1 | 2004 | 158 | 0.050 |
Why?
|
| Mice, SCID | 2 | 2016 | 579 | 0.050 |
Why?
|
| In Vitro Techniques | 6 | 1999 | 824 | 0.050 |
Why?
|
| Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 1982 | 7 | 0.050 |
Why?
|
| Receptors, LH | 1 | 2002 | 15 | 0.050 |
Why?
|
| Receptors, Opioid, delta | 1 | 2002 | 12 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2003 | 82 | 0.050 |
Why?
|
| Salmonella typhimurium | 1 | 1982 | 43 | 0.050 |
Why?
|
| Uridine Diphosphate | 1 | 2022 | 4 | 0.050 |
Why?
|
| Immune Sera | 2 | 1981 | 84 | 0.050 |
Why?
|
| Neoplastic Processes | 1 | 2022 | 6 | 0.050 |
Why?
|
| Protein Biosynthesis | 2 | 2005 | 580 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 1997 | 334 | 0.050 |
Why?
|
| Prostatic Hyperplasia | 1 | 2003 | 119 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2000 | 189 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2004 | 375 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2002 | 188 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2002 | 161 | 0.050 |
Why?
|
| Middle Aged | 3 | 2017 | 28911 | 0.050 |
Why?
|
| Biological Transport | 1 | 2002 | 333 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 1001 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2004 | 300 | 0.050 |
Why?
|
| Androgen-Binding Protein | 1 | 2001 | 26 | 0.040 |
Why?
|
| Ketones | 1 | 2001 | 27 | 0.040 |
Why?
|
| Bone Density | 1 | 2004 | 363 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2002 | 275 | 0.040 |
Why?
|
| Biphenyl Compounds | 1 | 2001 | 75 | 0.040 |
Why?
|
| Actins | 1 | 2003 | 317 | 0.040 |
Why?
|
| Flutamide | 2 | 2001 | 26 | 0.040 |
Why?
|
| Estradiol | 2 | 2014 | 481 | 0.040 |
Why?
|
| Arabidopsis Proteins | 1 | 2001 | 57 | 0.040 |
Why?
|
| Ovarian Neoplasms | 1 | 2004 | 455 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2000 | 12 | 0.040 |
Why?
|
| Tyrosine | 2 | 1999 | 148 | 0.040 |
Why?
|
| Progesterone Congeners | 2 | 2000 | 5 | 0.040 |
Why?
|
| Cloning, Molecular | 5 | 1993 | 787 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 2000 | 56 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1990 | 255 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2000 | 122 | 0.040 |
Why?
|
| Okadaic Acid | 3 | 1994 | 12 | 0.040 |
Why?
|
| Endocrine System | 1 | 1999 | 18 | 0.040 |
Why?
|
| Cysteine | 2 | 1999 | 140 | 0.040 |
Why?
|
| Xenobiotics | 1 | 1999 | 27 | 0.040 |
Why?
|
| Response Elements | 1 | 1999 | 99 | 0.040 |
Why?
|
| Genes | 2 | 1990 | 308 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2004 | 765 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2002 | 1088 | 0.040 |
Why?
|
| Hypercalcemia | 1 | 1999 | 42 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1996 | 121 | 0.040 |
Why?
|
| beta-Galactosidase | 2 | 1997 | 135 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 1999 | 77 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2000 | 138 | 0.040 |
Why?
|
| Binding, Competitive | 4 | 2004 | 151 | 0.040 |
Why?
|
| X Chromosome | 1 | 1999 | 331 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 1999 | 112 | 0.040 |
Why?
|
| Radiopharmaceuticals | 1 | 1999 | 165 | 0.040 |
Why?
|
| Environmental Pollutants | 1 | 1999 | 81 | 0.040 |
Why?
|
| A549 Cells | 1 | 2018 | 49 | 0.040 |
Why?
|
| Androstenes | 1 | 2017 | 8 | 0.030 |
Why?
|
| Macromolecular Substances | 7 | 1992 | 141 | 0.030 |
Why?
|
| Time Factors | 3 | 2005 | 6285 | 0.030 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 1997 | 18 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 602 | 0.030 |
Why?
|
| Antigen-Antibody Complex | 3 | 1989 | 60 | 0.030 |
Why?
|
| Bacterial Proteins | 2 | 1982 | 943 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2004 | 1951 | 0.030 |
Why?
|
| Neoplasm Metastasis | 2 | 2016 | 710 | 0.030 |
Why?
|
| Benzamides | 1 | 2017 | 124 | 0.030 |
Why?
|
| Benzazepines | 1 | 1997 | 44 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 1999 | 1069 | 0.030 |
Why?
|
| Models, Structural | 1 | 1996 | 42 | 0.030 |
Why?
|
| Dopamine Agonists | 1 | 1997 | 55 | 0.030 |
Why?
|
| Testosterone | 1 | 2002 | 604 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1996 | 54 | 0.030 |
Why?
|
| Antigens, Nuclear | 1 | 1997 | 52 | 0.030 |
Why?
|
| Immunoblotting | 3 | 1992 | 291 | 0.030 |
Why?
|
| Colforsin | 1 | 1996 | 46 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2017 | 188 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 2123 | 0.030 |
Why?
|
| Chromones | 1 | 2015 | 26 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2009 | 590 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 2368 | 0.030 |
Why?
|
| Retinoic Acid Receptor alpha | 2 | 2006 | 18 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 910 | 0.030 |
Why?
|
| Morpholines | 1 | 2015 | 68 | 0.030 |
Why?
|
| DNA Helicases | 1 | 1997 | 235 | 0.030 |
Why?
|
| Mediator Complex | 1 | 2015 | 61 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2016 | 230 | 0.030 |
Why?
|
| Casein Kinase II | 1 | 1994 | 12 | 0.030 |
Why?
|
| Precipitin Tests | 3 | 2002 | 137 | 0.030 |
Why?
|
| Estrogen Receptor Antagonists | 1 | 2014 | 4 | 0.030 |
Why?
|
| Androstenedione | 1 | 2014 | 15 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 381 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2005 | 1545 | 0.030 |
Why?
|
| Vanadates | 1 | 1994 | 8 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 198 | 0.030 |
Why?
|
| RNA Interference | 1 | 2016 | 495 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1998 | 694 | 0.030 |
Why?
|
| Protein Phosphatase 2 | 1 | 1994 | 33 | 0.030 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2014 | 93 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 209 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 1522 | 0.030 |
Why?
|
| Protein Phosphatase 1 | 1 | 1994 | 53 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1994 | 428 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1995 | 335 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1994 | 240 | 0.030 |
Why?
|
| DNA Repair | 1 | 1997 | 577 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2004 | 3425 | 0.030 |
Why?
|
| Ovalbumin | 2 | 1990 | 119 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1993 | 59 | 0.020 |
Why?
|
| Cell Survival | 2 | 2009 | 854 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1993 | 125 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 241 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 1992 | 201 | 0.020 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 1992 | 55 | 0.020 |
Why?
|
| Autoradiography | 1 | 1992 | 65 | 0.020 |
Why?
|
| Phosphoproteins | 2 | 1993 | 430 | 0.020 |
Why?
|
| Attitude | 1 | 2012 | 112 | 0.020 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 2 | 2003 | 70 | 0.020 |
Why?
|
| Amino Acid Substitution | 2 | 2003 | 410 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2002 | 41 | 0.020 |
Why?
|
| Program Development | 1 | 2012 | 181 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1991 | 39 | 0.020 |
Why?
|
| Rabbits | 2 | 1989 | 633 | 0.020 |
Why?
|
| Cell-Free System | 4 | 1991 | 62 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2012 | 442 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 1990 | 45 | 0.020 |
Why?
|
| Species Specificity | 2 | 1999 | 519 | 0.020 |
Why?
|
| Corticosterone | 1 | 1990 | 53 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2012 | 443 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 2 | 2007 | 1131 | 0.020 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2009 | 2 | 0.020 |
Why?
|
| Risk Factors | 1 | 2004 | 10998 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2017 | 1618 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2009 | 60 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2009 | 136 | 0.020 |
Why?
|
| Phosphates | 3 | 1996 | 110 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2011 | 254 | 0.020 |
Why?
|
| Luminescent Proteins | 2 | 2000 | 157 | 0.020 |
Why?
|
| Epidermal Growth Factor | 2 | 2000 | 116 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2009 | 312 | 0.020 |
Why?
|
| Osmolar Concentration | 2 | 2004 | 148 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 5298 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 2 | 2000 | 382 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 3708 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2009 | 301 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2009 | 256 | 0.020 |
Why?
|
| Kidney | 1 | 1994 | 1304 | 0.020 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2007 | 103 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2009 | 450 | 0.020 |
Why?
|
| Templates, Genetic | 3 | 1991 | 54 | 0.020 |
Why?
|
| Retinoids | 1 | 2006 | 29 | 0.020 |
Why?
|
| Ubiquitins | 2 | 1999 | 39 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 1008 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2006 | 118 | 0.010 |
Why?
|
| Ultraviolet Rays | 2 | 2005 | 195 | 0.010 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2004 | 2 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 4961 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2006 | 312 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 3 | 2000 | 1020 | 0.010 |
Why?
|
| Genes, ras | 1 | 2005 | 99 | 0.010 |
Why?
|
| Keratinocytes | 1 | 2004 | 74 | 0.010 |
Why?
|
| Histidine | 2 | 1982 | 74 | 0.010 |
Why?
|
| Ubiquitin | 1 | 2005 | 133 | 0.010 |
Why?
|
| Caspases | 1 | 2004 | 157 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 2004 | 182 | 0.010 |
Why?
|
| Texas | 1 | 2012 | 3629 | 0.010 |
Why?
|
| Myotonin-Protein Kinase | 1 | 2003 | 39 | 0.010 |
Why?
|
| Luciferases | 1 | 2003 | 127 | 0.010 |
Why?
|
| Phosphoamino Acids | 1 | 2002 | 1 | 0.010 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2002 | 14 | 0.010 |
Why?
|
| Cathepsin D | 1 | 2002 | 16 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 1982 | 79 | 0.010 |
Why?
|
| Trinucleotide Repeats | 1 | 2003 | 106 | 0.010 |
Why?
|
| Estrogen Receptor beta | 1 | 2003 | 77 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 3 | 1989 | 54 | 0.010 |
Why?
|
| Chorionic Gonadotropin | 1 | 2002 | 80 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2002 | 194 | 0.010 |
Why?
|
| Immunization | 1 | 1984 | 307 | 0.010 |
Why?
|
| Endocytosis | 1 | 2002 | 129 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2012 | 4058 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 609 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2001 | 36 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 13011 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2001 | 67 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2002 | 596 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2002 | 363 | 0.010 |
Why?
|
| Sheep | 1 | 1981 | 225 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2003 | 803 | 0.010 |
Why?
|
| Sexual Maturation | 1 | 2001 | 46 | 0.010 |
Why?
|
| Urogenital System | 1 | 2001 | 35 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2001 | 261 | 0.010 |
Why?
|
| Random Allocation | 1 | 2001 | 423 | 0.010 |
Why?
|
| CREB-Binding Protein | 1 | 2000 | 55 | 0.010 |
Why?
|
| Disorders of Sex Development | 1 | 2001 | 71 | 0.010 |
Why?
|
| Oligonucleotide Probes | 2 | 1990 | 87 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 2000 | 78 | 0.010 |
Why?
|
| Fluorine Radioisotopes | 1 | 1999 | 12 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 1489 | 0.010 |
Why?
|
| Solutions | 1 | 1999 | 53 | 0.010 |
Why?
|
| NEDD8 Protein | 1 | 1999 | 12 | 0.010 |
Why?
|
| Haplorhini | 1 | 1999 | 106 | 0.010 |
Why?
|
| Fushi Tarazu Transcription Factors | 1 | 1999 | 7 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1999 | 74 | 0.010 |
Why?
|
| Skin Diseases | 1 | 2001 | 141 | 0.010 |
Why?
|
| Cell Death | 1 | 2000 | 237 | 0.010 |
Why?
|
| Steroidogenic Factor 1 | 1 | 1999 | 35 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 21279 | 0.010 |
Why?
|
| Menopause | 1 | 1999 | 87 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 1982 | 485 | 0.010 |
Why?
|
| Muscular Atrophy | 1 | 2000 | 83 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 2000 | 129 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 107 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1999 | 366 | 0.010 |
Why?
|
| Testis | 1 | 2001 | 413 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1981 | 812 | 0.010 |
Why?
|
| Mitosis | 1 | 1999 | 190 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2000 | 269 | 0.010 |
Why?
|
| Myocardium | 1 | 2003 | 876 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1999 | 265 | 0.010 |
Why?
|
| Body Weight | 1 | 2001 | 990 | 0.010 |
Why?
|
| Reproduction | 1 | 1999 | 217 | 0.010 |
Why?
|
| Ku Autoantigen | 1 | 1997 | 21 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1999 | 366 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 1999 | 262 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 1004 | 0.010 |
Why?
|
| Baculoviridae | 1 | 1996 | 41 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2000 | 1325 | 0.010 |
Why?
|
| Prevalence | 1 | 2003 | 2697 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1998 | 519 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 1999 | 569 | 0.010 |
Why?
|
| Estrenes | 1 | 1995 | 16 | 0.010 |
Why?
|
| Escherichia coli | 2 | 1990 | 984 | 0.010 |
Why?
|
| Sexual Behavior, Animal | 1 | 1995 | 60 | 0.010 |
Why?
|
| Posture | 1 | 1995 | 136 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 2000 | 557 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1994 | 160 | 0.010 |
Why?
|
| Dopamine | 1 | 1995 | 256 | 0.010 |
Why?
|
| Acetyl Coenzyme A | 1 | 1993 | 15 | 0.010 |
Why?
|
| Age Factors | 1 | 1999 | 2869 | 0.010 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1992 | 13 | 0.010 |
Why?
|
| Isoquinolines | 1 | 1992 | 42 | 0.010 |
Why?
|
| Genes, Fungal | 1 | 1991 | 60 | 0.010 |
Why?
|
| Cricetulus | 1 | 1991 | 88 | 0.010 |
Why?
|
| Chromatography, Gel | 2 | 1987 | 78 | 0.010 |
Why?
|
| CHO Cells | 1 | 1991 | 149 | 0.010 |
Why?
|
| Y-Box-Binding Protein 1 | 1 | 1991 | 10 | 0.010 |
Why?
|
| Cricetinae | 1 | 1991 | 367 | 0.010 |
Why?
|
| Imidoesters | 1 | 1990 | 2 | 0.010 |
Why?
|
| NFI Transcription Factors | 1 | 1991 | 50 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1990 | 50 | 0.010 |
Why?
|
| Ammonium Sulfate | 1 | 1989 | 4 | 0.000 |
Why?
|
| Thymidine Kinase | 1 | 1990 | 89 | 0.000 |
Why?
|
| Simplexvirus | 1 | 1990 | 100 | 0.000 |
Why?
|
| Methylation | 1 | 1988 | 201 | 0.000 |
Why?
|
| Polymers | 1 | 1988 | 112 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1986 | 73 | 0.000 |
Why?
|
| Alleles | 1 | 1991 | 1713 | 0.000 |
Why?
|
| Proteins | 1 | 1971 | 1028 | 0.000 |
Why?
|
| Immunosorbent Techniques | 1 | 1984 | 24 | 0.000 |
Why?
|
| Triamcinolone Acetonide | 1 | 1984 | 20 | 0.000 |
Why?
|
| Epitopes | 1 | 1984 | 432 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1984 | 792 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 1984 | 4762 | 0.000 |
Why?
|
| Phosphoenolpyruvate | 1 | 1971 | 2 | 0.000 |
Why?
|
| Electrophoresis, Disc | 1 | 1971 | 11 | 0.000 |
Why?
|
| Phosphorus Isotopes | 1 | 1971 | 4 | 0.000 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1971 | 11 | 0.000 |
Why?
|
| Chromatography | 1 | 1971 | 35 | 0.000 |
Why?
|
| Ultracentrifugation | 1 | 1971 | 21 | 0.000 |
Why?
|
| Electrophoresis | 1 | 1971 | 38 | 0.000 |
Why?
|
| Spectrophotometry | 1 | 1971 | 55 | 0.000 |
Why?
|
| Hydrolysis | 1 | 1971 | 141 | 0.000 |
Why?
|
| Tryptophan | 1 | 1971 | 94 | 0.000 |
Why?
|
| Carbon Isotopes | 1 | 1971 | 230 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1971 | 144 | 0.000 |
Why?
|
| Amino Acids | 1 | 1971 | 620 | 0.000 |
Why?
|